1. Home
  2. BCDA vs RAY Comparison

BCDA vs RAY Comparison

Compare BCDA & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.20

Market Cap

12.7M

Sector

Health Care

ML Signal

HOLD

Logo Raytech Holding Limited Ordinary Shares

RAY

Raytech Holding Limited Ordinary Shares

N/A

Current Price

$3.87

Market Cap

11.7M

ML Signal

N/A

Company Overview

Basic Information
Metric
BCDA
RAY
Founded
N/A
1993
Country
United States
Hong Kong
Employees
17
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
12.7M
11.7M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BCDA
RAY
Price
$1.20
$3.87
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
69.1K
14.8K
Earning Date
03-24-2026
01-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.84
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.15
52 Week High
$3.20
$5.49

Technical Indicators

Market Signals
Indicator
BCDA
RAY
Relative Strength Index (RSI) 42.07 42.62
Support Level $1.10 $3.82
Resistance Level $1.39 $4.47
Average True Range (ATR) 0.09 0.23
MACD -0.01 -0.06
Stochastic Oscillator 17.21 34.82

Price Performance

Historical Comparison
BCDA
RAY

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About RAY Raytech Holding Limited Ordinary Shares

Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Men's Care and Women's Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; neck care series; nail care series; tooling and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, handy fan and others. Raytech manufactures products under OEM and ODM.

Share on Social Networks: